WNT SIGNALING AGONIST MOLECULES

Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.

Saved in:
Bibliographic Details
Main Authors Janda, Claudia Yvonne, Garcia, Kenan Christopher, Dang, Luke, Moody, James Daniel, Baker, David
Format Patent
LanguageEnglish
Published 30.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.
Bibliography:Application Number: US202117469661